Boston, MA and Copenhagen, Denmark - Two new studies published this week provide support for the role of nonfasting triglyceride levels as a significant risk factor for coronary heart disease [1,2].

Researchers sought to determine whether triglyceride levels were independently associated with cardiovascular disease among patients with coronary artery disease and type 2 diabetes. In patients with ...

The AHA has published a scientific statement regarding the screening, diagnosis, and management of hypertriglyceridemia in pediatric patients.

Hoth Therapeutics, Inc. (NASDAQ: HOTH), a clinical-stage biopharmaceutical company focused on developing innovative therapies for patients with unmet medical needs, today announced new female-specific ...

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com. Investigational therapy inhibits production of ...

Stroke can have many causes. An atherothrombotic stroke is caused by a clot that forms from plaques that build up within blood vessels in the brain. A new study suggests that people who have this type ...

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com. A monthly injection of olezarsen reduced triglyceride ...

Tryngolza (olezarsen) has been approved by the U.S. Food and Drug Administration as an adjunct to diet to reduce triglycerides in adults with familial chylomicronemia syndrome (FCS), which can lead to ...

Both doses of olezarsen significantly reduced triglyceride levels at 6 months compared with placebo (placebo-adjusted reduction, 50mg: 58%; 80mg: 61%; P .0001). Topline data were announced from a ...

Volanesorsen, an experimental drug, substantially reduces triglycerides in patients with a range of high baseline levels, according to a small, placebo-controlled study published in the July 30, 2015, ...

Older people with higher levels of triglycerides may have a lower risk of dementia and experience slower cognitive decline than those with lower triglyceride levels. The corresponding study was ...